Rocket Lab Corporation
Decision brief
RKLB closed at $63.89 on July 28, down 4.6% on the day, after a brief bounce from the $266M Space Force contract announcement faded. The at 18.2 and 10Y yield at 4.6% create a neutral-to-cautious macro environment that pressures high-multiple growth stocks. Revenue growth remains robust at 63.5% YoY, but the company is deeply unprofitable with a forward above 1,200x and negative FCF of -$215M. The Iridium acquisition adds dilution of 15-20% and integration risk. Technically, the stock is decisively below the 200-day ($77.59) and 50-day ($87.54), with at 33.1 in oversold territory but no bullish divergence. Insider selling persists without any open-market purchases. Next earnings on August 10, 12 days away, is a binary event. The contract win improves the long-term pipeline but does not alter near-term cash burn or the bearish technical setup. Maintain HOLD with cautious bias; the downtrend is intact but oversold conditions could produce a bounce.
Decision
$63.89
Recommendation score
40%Confidence
30%Outlook by horizon
1M
Near
6M
Mid
1Y
Long
Primary catalyst
The Q2 earnings report on August 10, 2026 (12 days away) is the highest-impact catalyst. The stock could move 15%+ in either direction depending on Iridium integration updates, Neutron timeline, and cash burn guidance. A beat could lift the stock toward $78, while a miss could push it below $60.
Price rail
$58.00
$58.00 - $62.00
$78.00 - $83.00
Risk / reward
10.0x
Downside to stop
-9.2%
Upside to exit
+29.9%
Position sizing
Given speculative nature, high volatility, and binary earnings event, position sizes should be limited to 5-10% of normal for aggressive portfolios only. Conservative accounts should avoid entirely. Short positions could be considered with tight stops, but the contract win may trigger a short squeeze (short percent of float at 7.97%).
Why It Works
What Breaks It
The stock has broken below its 200-day and is in a confirmed downtrend. Insider selling by the CFO, GC, and directors indicates a lack of confidence at the top. The Iridium deal will dilute shareholders by 15-20% and adds integration complexity that could distract from Neutron development. Negative estimate revisions suggest near-term earnings will disappoint. Piper Sandler's Neutral initiation with an $83 target caps near-term upside. The extreme valuation (59x sales) leaves no margin for error. If Neutron is delayed or the Iridium deal fails to achieve expected synergies, the stock could fall to $50 or lower.
A weekly close above $78 (near the 200-day and 20-day ) on strong volume would invalidate the bearish breakdown and suggest a false breakdown, potentially opening a move to $90+. Conversely, a weekly close below $60 would confirm further downside and invalidate any bounce thesis, likely leading to $50.
Watch Next
Decision inputs
6 signalsFundamental
78.9%
Upside to analyst mean target
RKLB trades at a of 59x TTM, extreme even for high-growth aerospace. With negative earnings and a forward of 1,229x, traditional valuation is not meaningful. Enterprise value of $37.5B is 94% of market cap due to $1.38B cash. The mean analyst target of $114 implies 79% upside, but targets are stale and the low target of $77 from Piper Sandler's Neutral initiation is more realistic. The FCF yield of -0.54% offers no margin of safety.
Technical
Bearish
Trend quality
Price at $63.89 is decisively below the 200-day ($77.59) and the 50-day ($87.54), which bearishly crossed below the 200-day (death cross) earlier in July. The stock has been in a clear downtrend of lower highs and lower lows since the May peak of $151. The 20-day at $78.08 is falling rapidly. The breakdown below $80 on heavy volume confirmed the bearish trend.
Earnings
12d
Turning Positive
Q1 2026 beat estimates by $0.009 (11% surprise) with of -$0.07, driven by record revenue. The stock reacted positively but the Iridium deal overhang capped gains.
News
Mixed-Bullish
Headline tone
The Q2 earnings report on August 10, 2026 (12 days away) is the highest-impact catalyst. The stock could move 15%+ in either direction depending on Iridium integration updates, Neutron timeline, and cash burn guidance. A beat could lift the stock toward $78, while a miss could push it below $60.
Macro
Neutral
4.60% 10Y / 18.2 VIX
at 18.2 and 10-year yield at 4.6% create a cautious environment where high-multiple, long-duration names like RKLB are penalized. Rising yields compress valuation on pre-profit growth stocks, and the Nasdaq's slight decline on July 28 reflects ongoing rotation away from speculative names.
Stability
Speculative / Binary
Satellite Upside
Rocket Lab remains unprofitable with negative free cash flow, trading at 59x sales despite strong revenue growth of 63.5% YoY. The $266M Space Force contract de-risks near-term revenue but does not change the fundamental path to profitability. The pending Iridium acquisition will dilute shareholders 15-20% and adds integration risk. Insider selling continues without any open-market purchases, signaling management caution. With earnings 12 days away and the stock in a bearish technical trend, drawdown risk is very high. The thesis is not durable until profitability or clear milestones on Neutron and Iridium synergies emerge. Suitable only as a small tactical satellite position within aggressive portfolios.
Mean Target
$114.33
High / Low
$77 / $150
Median Target
$120.00
Consensus range
$77 - $150
Consensus
The consensus is still Strong Buy (3 strong buy, 10 buy, 4 hold) but with a wide target range of $77-$150, indicating high uncertainty. The mean target of $114 is stale and likely overstates upside given the 58% decline from the May high. Recent analyst actions include KGI Securities upgrading to Outperform with $107 target and Piper Sandler's Neutral initiation at $83. The wide spread reflects deep disagreement about the Iridium deal and profitability path.
Insider Signal
Strong Sell
Net Bias
Sell-heavy
Insider Own.
0.8%
Institutional Own.
60.5%
Interpretation
Persistent insider selling by top executives and directors without any buying indicates continued lack of confidence in the near-term outlook, likely driven by dilution and integration risks from the Iridium acquisition.
Notable activity
CFO Adam Spice sold 62,512 shares ($435k), General Counsel Arjun Kampani sold 28,563 shares ($199k), and director Michael Griffin sold 39,446 shares ($272k) in recent filings. No open-market purchases were recorded. A large grant to director Possenriede (66,797 shares) is non-dilutive but not a buy signal.
Industry
Sentiment
6
Tracked names
5
Grouping
industry
Aerospace & Defense industry is currently Neutral with an average recommendation score near 52. positioning is broadly steady, and leadership is concentrated in SPCX, GE, BA.
Rotation Drivers
Leaders To Watch
Themes
Score: 10
Rocket Lab's record $266M Space Force contract positions it as a key defense launch provider, but the broader space sector remains in a steep downturn. The Procure Space ETF (UFO) is down significantly from its May high, indicating capital is rotating out of speculative space names. While defense spending tailwinds support the industry, RKLB's valuation and dilution risk cap upside. The theme is strengthening for established defense prime contractors but remains challenging for high-valuation space growth stocks.
The Space Force contract award on July 27 provides a powerful new revenue stream tied to national security, offering a buffer against the broader space sell-off.
Market Cap
$39.92B
P/E (TTM)
0.0
Forward P/E
1228.7
Revenue Growth
63.5%
ROE
-13.5%
Beta
2.55
Full Metric Set
17 additional stats
Valuation Stack
Multiples and cash-flow framing.
Price / Sales
58.7
Price / Book
16.2
EV / EBITDA
-227.5
Quality & Balance Sheet
Margins, leverage, and liquidity.
Gross Margin
36.6%
Operating Margin
-22.4%
Debt / Equity
6.1
Current Ratio
4.47x
Quick Ratio
3.87x
Positioning & Range
Short interest and 52-week location.
Short % Float
8.0%
Short Ratio
1.71x
52W High
$151.00
52W Low
$37.57
From 52W High
-57.7%
From 52W Low
70.1%
Company Classification
Sector and industry context.
Sector
Industrials
Industry
Aerospace & Defense
Additional Signals
Free Cash Flow
$-214999376.00
Business Quality
Capital Allocation
Estimate Revisions
Revenue Growth
63.5%
Insider Activity
POSSENRIEDE KENNETH R
Director
66,797
—
OLSON JON A
Director
42,353
—
GRIFFIN MICHAEL D
Director
39,446
$272k
KAMPANI ARJUN E
General Counsel
28,563
$199k
News Catalysts
Jul 28, 2026
Why Rocket Lab (RKLB) Stock Is Up Today
Shares of aerospace and defense company Rocket Lab (NASDAQ:RKLB) jumped 1.9% in the morning session after the company announced it was awarded its largest launch contract to date, a $266 million multi-launch deal with the U.S. Space Force.
Jul 27, 2026
Rocket Lab Stock Soars After Winning Biggest-Ever U.S. Space Force Deal
Rocket Lab Stock Gains as $266 Million Space Force Award Fuels Investor Optimism
Jul 27, 2026
Rocket Lab Wins Record $266 Million U.S. Space Force Contract
Rocket Lab received a $266 million U.S. Space Force contract, its largest agreement to date, for up to 18 suborbital launches that will support missile defense capabilities.
Jul 27, 2026
Rocket Lab Secures Biggest Launch Deal Yet as Space Demand Grows
Rocket Lab Corporation (NASDAQ:RKLB) shares are up during Monday’s premarket session as the company is awarded its largest launch contract to date. This $266 million contract with the U.S. Space Force involves executing 12 suborbital launches, expected to commence no earlier than the end of 2026. The contract awarded by the U.S. Space Force’s Rocket Systems Launch Program will enhance Rocket Lab’s capabilities in national security missions. Work will be performed at the Pacific Spaceport Complex